Paper
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients

https://doi.org/10.1016/0959-8049(94)90412-XGet rights and content

Abstract

The objective of this investigation was to determine factors predictive of bacteraemia at presentation in febrile, granulocytopenic cancer patients in order to estimate the probability of bacteraemia in each patient, and to compare factors associated with a diagnosis of gram-positive or gram-negative bacteraemia. Retrospective analysis of two sets of data (derivation and validation sets) randomly obtained from a large prospective study was conducted in a multicentre study of febrile, granulocytopenic cancer patients admitted for empiric antibacterial therapy. Within the derivation set, prognostic factors (clinical and laboratory data) likely to be associated with a generic diagnosis of bacteraemia and with a specific diagnosis of gram-positive or gram-negative bacteraemia were analysed by means of three backward, stepwise, logistic regression analyses. The predictive probability of bacteraemia was calculated using the logistic equation. The discriminating ability of the model in predicting bacteraemia was evaluated in the derivation and validation sets using receiver-operating characteristic curves. The predictive probability of gram-positive or gram-negative bacteraemia was not calculated. In the derivation set, 157 of 558 episodes (28%) were microbiologically documented bacteraemias. Predicting factors were antifungal prophylaxis, duration of granulocytopenia before fever, platelet count, highest fever, shock and presence and location of initial signs of infection. The variables institution, antibacterial prophylaxis and underlying disease showed borderline associations with bacteraemia. Shock was associated with gram-negative bacteraemia, while signs of infection at catheter site were predictive of gram-positive bacteraemia. Quinolone prophylaxis was negatively associated with gram-negative bacteraemia. When tested in the validation set, the model was poorly predictive, although a small subgroup of episodes (representing only 16% of the total sample size) with low risk of bacteraemia was identified. Factors predictive of bacteraemia can be identified, with discrimination between gram-positive and gram-negative aetiology. Further studies are warranted in order to improve the discriminant ability of the model.

References (30)

  • S Schimpff et al.

    Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

    N Engl J Med

    (1971)
  • Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer

    J Infect Dis

    (1988)
  • J Klastersky et al.

    Empiric antimicrobial therapy for febrile, granulocytopenic cancer patients: lessons from 4 EORTC trials

    Eur J Cancer Clin Oncol

    (1988)
  • Vanomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients

    J Infect Dis

    (1991)
  • Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients

    J Clin Oncol

    (1983)
  • Cited by (117)

    • Platelets in Host Defense: Experimental and Clinical Insights

      2019, Trends in Immunology
      Citation Excerpt :

      Together, these types of findings have supported the concept that platelets play a role in host defense against pathogens in humans. Along the same lines, another study focusing on neutropenic cancer patients with leukemia or solid tumors identified thrombocytopenia as an independent risk factor for hospital-acquired bacteremia in a multivariate analysis [99]. Moreover, a prospective study evaluating predictive factors for invasive bacterial infection among children with (hematological and solid) cancer, fever, and neutropenia identified a platelet count below 50 000/μl as a risk predictor for invasive bacterial infection [100].

    • The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: A risk for bacteraemia?

      2016, Clinical Microbiology and Infection
      Citation Excerpt :

      In neutropenic oncohaematological patients, chemotherapy-induced neutropenia is of concern because its duration and severity are narrowly related to the development of infection. Moreover, bacteraemia constitutes the most frequent cause of infection-related mortality, which occurs in 20–40% of febrile neutropenic patients [1]. To reduce the risk of infection, different antibiotic-based prophylaxis regimens, such as co-trimoxazole, cephalosporins or fluoroquinolones, have been assayed [2,3].

    • Antimicrobial Host Defense

      2012, Platelets, Third Edition
    View all citing articles on Scopus
    View full text